Isolation, characterization, and genomic analysis of bacteriophages against Pseudomonas aeruginosa clinical isolates from early and chronic cystic fibrosis patients for potential phage therapy

From National Research Council Canada

Download
  1. (PDF, 8.5 MiB)
  2. (ZIP, 758 KiB)
DOIResolve DOI: https://doi.org/10.3390/microorganisms13030511
AuthorSearch for: 1ORCID identifier: https://orcid.org/0000-0001-5322-3038; Search for: 1ORCID identifier: https://orcid.org/0009-0003-4452-9280; Search for: 1; Search for: 1; Search for: ; Search for: 2ORCID identifier: https://orcid.org/0000-0002-2207-3409; Search for: ORCID identifier: https://orcid.org/0000-0002-2462-7137; Search for: ORCID identifier: https://orcid.org/0000-0002-3925-9533; Search for: 1ORCID identifier: https://orcid.org/0000-0003-0176-9463; Search for: 1ORCID identifier: https://orcid.org/0000-0003-0958-7728
Affiliation
  1. National Research Council of Canada. Human Health Therapeutics
  2. National Research Council of Canada. Aquatic and Crop Resource Development
FunderSearch for: National Research Council of Canada. Postdoctoral Fellowship; Search for: Ideation Small Team Project Grant; Search for: National Program Office. Ideation New Beginning Grant; Search for: National Research Council of Canada. Vaccines and Emerging Infection Research Initiative
FormatText, Article
SubjectPseudomonas aeruginosa; cystic fibrosis; bacteriophage; lytic phage; antimicrobial resistance
Abstract
Publication date
PublisherMDPI
Licence
In
LanguageEnglish
Peer reviewedYes
Export citationExport as RIS
Report a correctionReport a correction (opens in a new tab)
Record identifierc8927f19-b8dc-4226-8fc6-3c616b20ea41
Record created2025-05-22
Record modified2025-11-03
Date modified: